State Street Corporation 13D and 13G filings for CLOVIS ONCOLOGY INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-11 1:58 pm Sale |
2022-03-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
2,619,477 1.840% |
-13,495,065 (-83.74%) |
Filing |
| 2022-02-11 07:57 am Purchase |
2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
16,114,542 12.400% |
5,655,198 (+54.07%) |
Filing |
| 2021-06-10 10:13 am Purchase |
2021-05-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
10,459,344 10.000% |
566,467 (+5.73%) |
Filing |
| 2021-04-12 11:52 am Sale |
2021-03-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
9,892,877 9.460% |
-4,642,995 (-31.94%) |
Filing |
| 2021-02-11 2:38 pm Unchanged |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
14,535,872 16.460% |
0 (Unchanged) |
Filing |
| 2021-01-11 10:01 am Purchase |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
14,535,872 16.460% |
5,297,141 (+57.34%) |
Filing |
| 2020-07-10 11:05 am Purchase |
2020-06-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
STATE STREET CORP STT |
9,238,731 10.510% |
5,577,282 (+152.32%) |
Filing |